ADDING HYDROCHLOROTHIAZIDE PROVIDES DOSE-DEPENDENT SEATED BLOOD PRESSURE REDUCTIONS IN PATIENTS WITH MODERATE-TO-SEVERE HYPERTENSION NOT CONTROLLED BY OLMESARTAN MEDOXOMIL 40MG

被引：0

作者：

Rump, L. ^{[1
]}

Sellin, L. ^{[1
]}

Ammentorp, B. ^{[2
]}

Schmitt, J. ^{[2
]}

Laeis, P. ^{[2
]}

机构：

[1] Univ Klinikum Duesseldorf, Klin Nephrol, Dusseldorf, Germany

[2] Daiichi Sankyo Europe GmbH, Munich, Germany

来源：

JOURNAL OF HYPERTENSION | 2010年 / 28卷

关键词：

D O I：

暂无

中图分类号：

R6 [外科学];

学科分类号：

1002 ; 100210 ;

摘要：

引用

页码：E109 / E110

页数：3

共 29 条

[21] Efficacy and Safety of a Stepped-Care Regimen Using Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide in Patients with Moderate-to-Severe Hypertension An Open-Label, Long-Term Study
Volpe, Massimo
Miele, Cristina
Haag, Uwe
CLINICAL DRUG INVESTIGATION, 2009, 29 (06) : 381 - 391
[22] Clinic and ambulatory blood pressure lowering effect of aliskiren/amlodipine/hydrochlorothiazide combination in patients with moderate-to-severe hypertension: a randomized active-controlled trial
Lacourciere, Yves
Taddei, Stefano
Konis, George
Fang, Hui
Severin, Thomas
Zhang, Jack
JOURNAL OF HYPERTENSION, 2012, 30 (10) : 2047 - 2055
[23] Efficacy of olmesartan/amlodipine combination therapy in reducing ambulatory blood pressure in moderate-to-severe hypertensive patients not controlled by amlodipine alone
Bilo, Grzegorz
Koch, Winfried
Hoshide, Satoshi
Parati, Gianfranco
HYPERTENSION RESEARCH, 2014, 37 (09) : 836 - 844
[24] Efficacy of olmesartan/amlodipine combination therapy in reducing ambulatory blood pressure in moderate-to-severe hypertensive patients not controlled by amlodipine alone
Grzegorz Bilo
Winfried Koch
Satoshi Hoshide
Gianfranco Parati
Hypertension Research, 2014, 37 : 836 - 844
[25] Olmesartan medoxomil lowers blood pressure as rapidly as amlodipine besylate in patients with mild to moderate hypertension: Results of a randomized, double-blind, placebo-controlled study
Chrysant, S
Wang, A
AMERICAN JOURNAL OF HYPERTENSION, 2004, 17 (05) : 102A - 102A
[26] SINGLE-PILL COMBINATION OF TELMISARTAN 80 MG/AMLODIPINE 10 MG PROVIDES SUPERIOR BLOOD PRESSURE REDUCTIONS IN PATIENTS WITH SEVERE HYPERTENSION: TEAMSTA SEVERE HTN STUDY
Neutel, J.
Mancia, G.
Black, H.
Dahlof, B.
Defeo, H.
Ley, L.
Vinisko, R.
JOURNAL OF HYPERTENSION, 2010, 28 : E46 - E46
[27] Aliskiren, an oral renin inhibitor, provides dose-dependent efficacy and sustained 24-hour blood pressure control in patients with hypertension
Oh, Byung-Hee
Mitchell, Jerry
Herron, James R.
Chung, Jenny
Khan, Mahmudul
Keefe, Deborah L.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 49 (11) : 1157 - 1163
[28] Aliskiren/Amlodipine/Hydrochlorothiazide Provides Significant Blood Pressure Reductions in Patients with Very Severe Hypertension (Systolic BP≥190 mmHg-<200 mm Hg)
Lacourciere, Yves
Taddei, Stefano
Konis, George
Salko, Thomas
Fang, Hui
Zhang, Jack
HYPERTENSION, 2010, 56 (05) : E134 - E134
[29] LOW-DOSE HYDROCHLOROTHIAZIDE (12.5 TO 25 MG DAILY) AS MONOTHERAPY IN BLACK PATIENTS WITH MILD-TO-MODERATE HYPERTENSION - ASSESSMENT BY AMBULATORY BLOOD-PRESSURE MONITORING
SKOULARIGIS, J
STRUGO, V
CHOPAMBA, A
SETEKGE, S
SARELI, P
AMERICAN JOURNAL OF HYPERTENSION, 1995, 8 (10) : 1046 - 1050

← 1 2 3 →